LINC02132

Across TCGA pan-cancer cohorts, LINC02132 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated LINC02132 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher LINC02132 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC02132 expression acts as an unfavorable survival marker, although some lineages such as SKCM and LUAD show a favorable association.

SKCM, LUAD, and BRCA are the cancer types where LINC02132 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Tertile	II,III,IV	0.363	0.200	<.001	103	view →
LUAD	OS	Median	All	0.465	0.286	<.001	60	view →
BRCA	OS	Median	All	0.977	0.947	<.001	51	view →
STAD	OS	Quartile	IV	0.845	0.249	.008	33	view →
HNSC	DFS	Median	All	0.758	0.664	.006	26	view →
LAML	DFS	Tertile	All	0.312	0.568	.007	24	view →
CESC	DFS	Tertile	All	0.890	0.769	.007	20	view →
SARC	OS	Quartile	All	0.874	0.678	<.001	19	view →
KICH	OS	Tertile	II,III,IV	0.714	0.965	.013	17	view →
THYM	OS	Median	II,III,IV	1.000	0.645	.009	13	view →
ACC	OS	Tertile	II,III,IV	0.362	0.701	.020	12	view →
DLBC	DFS	Median	All	1.000	0.649	.024	11	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

LINC02132–SKCM (DFS)

Open the SKCM breakdown →